Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 410

1.

A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.

Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH.

Arch Dermatol. 2000 Feb;136(2):179-84.

PMID:
10677093
2.

Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.

Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM.

J Natl Cancer Inst. 1996 Dec 18;88(24):1848-53.

PMID:
8961975
3.

Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.

Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.

Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):157-61.

4.

Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.

Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH.

J Natl Cancer Inst. 1999 Dec 15;91(24):2102-6.

PMID:
10601381
5.

Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.

Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group.

J Natl Cancer Inst. 2003 Oct 1;95(19):1477-81.

PMID:
14519754
6.

Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma.

Cook NR, Stampfer MJ, Ma J, Manson JE, Sacks FM, Buring JE, Hennekens CH.

Cancer. 1999 Nov 1;86(9):1783-92.

PMID:
10547552
7.

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.

Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK.

J Natl Cancer Inst. 1996 Nov 6;88(21):1560-70.

PMID:
8901854
8.

Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.

Moon TE, Levine N, Cartmel B, Bangert JL, Rodney S, Dong Q, Peng YM, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):949-56.

9.

Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.

Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA; VATTC Trial.

J Natl Cancer Inst. 2008 Sep 3;100(17):1223-32. doi: 10.1093/jnci/djn262. Epub 2008 Aug 26.

PMID:
18728281
10.

Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).

Cook NR, Le IM, Manson JE, Buring JE, Hennekens CH.

Cancer Causes Control. 2000 Aug;11(7):617-26.

PMID:
10977106
12.

Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.

Mayne ST, Cartmel B, Baum M, Shor-Posner G, Fallon BG, Briskin K, Bean J, Zheng T, Cooper D, Friedman C, Goodwin WJ Jr.

Cancer Res. 2001 Feb 15;61(4):1457-63.

13.

Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.

Leppälä JM, Virtamo J, Fogelholm R, Albanes D, Taylor PR, Heinonen OP.

Arch Neurol. 2000 Oct;57(10):1503-9.

PMID:
11030804
14.

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.

Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R.

N Engl J Med. 1996 May 2;334(18):1145-9.

16.

The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial.

Rautalahti MT, Virtamo JR, Taylor PR, Heinonen OP, Albanes D, Haukka JK, Edwards BK, Kärkkäinen PA, Stolzenberg-Solomon RZ, Huttunen J.

Cancer. 1999 Jul 1;86(1):37-42.

PMID:
10391561
17.

The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.

Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briançon S.

Arch Intern Med. 2004 Nov 22;164(21):2335-42. Erratum in: Arch Intern Med. 2005 Feb 14;165(3):286.

18.

Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.

Nugent Z, Demers AA, Wiseman MC, Mihalcioiu C, Kliewer EV.

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2584-90.

19.

A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group.

Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DW, Bayrd G, et al.

N Engl J Med. 1990 Sep 20;323(12):789-95. Erratum in: N Engl J Med 1991 Oct 31;325(18):1324.

20.

Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report.

Chuang TY, Reizner GT, Elpern DJ, Stone JL, Farmer ER.

J Am Acad Dermatol. 1995 Sep;33(3):422-6.

PMID:
7657865

Supplemental Content

Support Center